Table of Content

1 Plasma Derived Medicine Market Overview
1.1 Product Overview and Scope of Plasma Derived Medicine
1.2 Plasma Derived Medicine Segment by Type
1.2.1 Global Plasma Derived Medicine Market Value Comparison by Type (2024-2034)
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.2.5 Others
1.3 Plasma Derived Medicine Segment by Application
1.3.1 Global Plasma Derived Medicine Market Value by Application: (2024-2034)
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Global Plasma Derived Medicine Market Size Estimates and Forecasts
1.4.1 Global Plasma Derived Medicine Revenue 2018-2029
1.4.2 Global Plasma Derived Medicine Sales 2018-2029
1.4.3 Global Plasma Derived Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Plasma Derived Medicine Market Competition by Manufacturers
2.1 Global Plasma Derived Medicine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Plasma Derived Medicine Average Price by Manufacturers (2018-2024)
2.4 Global Plasma Derived Medicine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Plasma Derived Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Derived Medicine, Product Type & Application
2.7 Plasma Derived Medicine Market Competitive Situation and Trends
2.7.1 Plasma Derived Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Derived Medicine Players Market Share by Revenue
2.7.3 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Derived Medicine Retrospective Market Scenario by Region
3.1 Global Plasma Derived Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Plasma Derived Medicine Global Plasma Derived Medicine Sales by Region: 2018-2029
3.2.1 Global Plasma Derived Medicine Sales by Region: 2018-2024
3.2.2 Global Plasma Derived Medicine Sales by Region: 2024-2029
3.3 Global Plasma Derived Medicine Global Plasma Derived Medicine Revenue by Region: 2018-2029
3.3.1 Global Plasma Derived Medicine Revenue by Region: 2018-2024
3.3.2 Global Plasma Derived Medicine Revenue by Region: 2024-2029
3.4 North America Plasma Derived Medicine Market Facts & Figures by Country
3.4.1 North America Plasma Derived Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Plasma Derived Medicine Sales by Country (2018-2029)
3.4.3 North America Plasma Derived Medicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Plasma Derived Medicine Market Facts & Figures by Country
3.5.1 Europe Plasma Derived Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Plasma Derived Medicine Sales by Country (2018-2029)
3.5.3 Europe Plasma Derived Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Derived Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Derived Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Plasma Derived Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Plasma Derived Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Plasma Derived Medicine Market Facts & Figures by Country
3.7.1 Latin America Plasma Derived Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Plasma Derived Medicine Sales by Country (2018-2029)
3.7.3 Latin America Plasma Derived Medicine Revenue by Country (2018-2029)
3.7.4 Brazil
3.8 Middle East and Africa Plasma Derived Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Derived Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Plasma Derived Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Plasma Derived Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 GCC Countries
3.8.6 Egypt
3.8.7 South Africa
4 Segment by Type
4.1 Global Plasma Derived Medicine Sales by Type (2018-2029)
4.1.1 Global Plasma Derived Medicine Sales by Type (2018-2024)
4.1.2 Global Plasma Derived Medicine Sales by Type (2024-2029)
4.1.3 Global Plasma Derived Medicine Sales Market Share by Type (2018-2029)
4.2 Global Plasma Derived Medicine Revenue by Type (2018-2029)
4.2.1 Global Plasma Derived Medicine Revenue by Type (2018-2024)
4.2.2 Global Plasma Derived Medicine Revenue by Type (2024-2029)
4.2.3 Global Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Plasma Derived Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Plasma Derived Medicine Sales by Application (2018-2029)
5.1.1 Global Plasma Derived Medicine Sales by Application (2018-2024)
5.1.2 Global Plasma Derived Medicine Sales by Application (2024-2029)
5.1.3 Global Plasma Derived Medicine Sales Market Share by Application (2018-2029)
5.2 Global Plasma Derived Medicine Revenue by Application (2018-2029)
5.2.1 Global Plasma Derived Medicine Revenue by Application (2018-2024)
5.2.2 Global Plasma Derived Medicine Revenue by Application (2024-2029)
5.2.3 Global Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Plasma Derived Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Takeda Plasma Derived Medicine Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CSL Plasma Derived Medicine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Grifols Plasma Derived Medicine Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Octapharma Plasma Derived Medicine Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Kedrion Plasma Derived Medicine Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 LFB Group Plasma Derived Medicine Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Biotest Plasma Derived Medicine Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 BPL Plasma Derived Medicine Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Shanghai RAAS Plasma Derived Medicine Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 China Biologic Products
6.10.1 China Biologic Products Corporation Information
6.10.2 China Biologic Products Description and Business Overview
6.10.3 China Biologic Products Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 China Biologic Products Plasma Derived Medicine Product Portfolio
6.10.5 China Biologic Products Recent Developments/Updates
6.11 Hualan Biological Engineering Inc.
6.11.1 Hualan Biological Engineering Inc. Corporation Information
6.11.2 Hualan Biological Engineering Inc. Plasma Derived Medicine Description and Business Overview
6.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Portfolio
6.11.5 Hualan Biological Engineering Inc. Recent Developments/Updates
6.12 Beijing Tiantan Biological Products Corp
6.12.1 Beijing Tiantan Biological Products Corp Corporation Information
6.12.2 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Description and Business Overview
6.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Portfolio
6.12.5 Beijing Tiantan Biological Products Corp Recent Developments/Updates
6.13 Pacific Shuanglin
6.13.1 Pacific Shuanglin Corporation Information
6.13.2 Pacific Shuanglin Plasma Derived Medicine Description and Business Overview
6.13.3 Pacific Shuanglin Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Pacific Shuanglin Plasma Derived Medicine Product Portfolio
6.13.5 Pacific Shuanglin Recent Developments/Updates
6.14 Boya Bio-Pharmaceutical
6.14.1 Boya Bio-Pharmaceutical Corporation Information
6.14.2 Boya Bio-Pharmaceutical Plasma Derived Medicine Description and Business Overview
6.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Portfolio
6.14.5 Boya Bio-Pharmaceutical Recent Developments/Updates
6.15 Paisi Feike Biology Pharmacy Co., Ltd.
6.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
6.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Description and Business Overview
6.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Portfolio
6.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
6.16 Xinjiang Deyuan Bioengineering
6.16.1 Xinjiang Deyuan Bioengineering Corporation Information
6.16.2 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Description and Business Overview
6.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Portfolio
6.16.5 Xinjiang Deyuan Bioengineering Recent Developments/Updates
6.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
6.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
6.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Description and Business Overview
6.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Portfolio
6.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Shenzhen Weiguang
6.18.1 Shenzhen Weiguang Corporation Information
6.18.2 Shenzhen Weiguang Plasma Derived Medicine Description and Business Overview
6.18.3 Shenzhen Weiguang Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Shenzhen Weiguang Plasma Derived Medicine Product Portfolio
6.18.5 Shenzhen Weiguang Recent Developments/Updates
6.19 Shanxi Kangbao
6.19.1 Shanxi Kangbao Corporation Information
6.19.2 Shanxi Kangbao Plasma Derived Medicine Description and Business Overview
6.19.3 Shanxi Kangbao Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Shanxi Kangbao Plasma Derived Medicine Product Portfolio
6.19.5 Shanxi Kangbao Recent Developments/Updates
6.20 Nanyue Biopharming Corporation Ltd
6.20.1 Nanyue Biopharming Corporation Ltd Corporation Information
6.20.2 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Description and Business Overview
6.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Portfolio
6.20.5 Nanyue Biopharming Corporation Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Derived Medicine Industry Chain Analysis
7.2 Plasma Derived Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Derived Medicine Production Mode & Process
7.4 Plasma Derived Medicine Sales and Marketing
7.4.1 Plasma Derived Medicine Sales Channels
7.4.2 Plasma Derived Medicine Distributors
7.5 Plasma Derived Medicine Customers
8 Plasma Derived Medicine Market Dynamics
8.1 Plasma Derived Medicine Industry Trends
8.2 Plasma Derived Medicine Market Drivers
8.3 Plasma Derived Medicine Market Challenges
8.4 Plasma Derived Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Plasma Derived Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Plasma Derived Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Plasma Derived Medicine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Plasma Derived Medicine Sales (K Bottles) of Key Manufacturers (2018-2024)
Table 5. Global Plasma Derived Medicine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Plasma Derived Medicine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Plasma Derived Medicine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Plasma Derived Medicine Average Price (USD/Bottle) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Plasma Derived Medicine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Plasma Derived Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plasma Derived Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Plasma Derived Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma Derived Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Plasma Derived Medicine Sales by Region (2018-2024) & (K Bottles)
Table 18. Global Plasma Derived Medicine Sales Market Share by Region (2018-2024)
Table 19. Global Plasma Derived Medicine Sales by Region (2024-2029) & (K Bottles)
Table 20. Global Plasma Derived Medicine Sales Market Share by Region (2024-2029)
Table 21. Global Plasma Derived Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Plasma Derived Medicine Revenue Market Share by Region (2018-2024)
Table 23. Global Plasma Derived Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Plasma Derived Medicine Revenue Market Share by Region (2024-2029)
Table 25. North America Plasma Derived Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Plasma Derived Medicine Sales by Country (2018-2024) & (K Bottles)
Table 27. North America Plasma Derived Medicine Sales by Country (2024-2029) & (K Bottles)
Table 28. North America Plasma Derived Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Plasma Derived Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Plasma Derived Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Plasma Derived Medicine Sales by Country (2018-2024) & (K Bottles)
Table 32. Europe Plasma Derived Medicine Sales by Country (2024-2029) & (K Bottles)
Table 33. Europe Plasma Derived Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Plasma Derived Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Plasma Derived Medicine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Plasma Derived Medicine Sales by Region (2018-2024) & (K Bottles)
Table 37. Asia Pacific Plasma Derived Medicine Sales by Region (2024-2029) & (K Bottles)
Table 38. Asia Pacific Plasma Derived Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Plasma Derived Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Plasma Derived Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Plasma Derived Medicine Sales by Country (2018-2024) & (K Bottles)
Table 42. Latin America Plasma Derived Medicine Sales by Country (2024-2029) & (K Bottles)
Table 43. Latin America Plasma Derived Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Plasma Derived Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Plasma Derived Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Plasma Derived Medicine Sales by Country (2018-2024) & (K Bottles)
Table 47. Middle East & Africa Plasma Derived Medicine Sales by Country (2024-2029) & (K Bottles)
Table 48. Middle East & Africa Plasma Derived Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Plasma Derived Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Plasma Derived Medicine Sales (K Bottles) by Type (2018-2024)
Table 51. Global Plasma Derived Medicine Sales (K Bottles) by Type (2024-2029)
Table 52. Global Plasma Derived Medicine Sales Market Share by Type (2018-2024)
Table 53. Global Plasma Derived Medicine Sales Market Share by Type (2024-2029)
Table 54. Global Plasma Derived Medicine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Plasma Derived Medicine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Plasma Derived Medicine Revenue Market Share by Type (2018-2024)
Table 57. Global Plasma Derived Medicine Revenue Market Share by Type (2024-2029)
Table 58. Global Plasma Derived Medicine Price (USD/Bottle) by Type (2018-2024)
Table 59. Global Plasma Derived Medicine Price (USD/Bottle) by Type (2024-2029)
Table 60. Global Plasma Derived Medicine Sales (K Bottles) by Application (2018-2024)
Table 61. Global Plasma Derived Medicine Sales (K Bottles) by Application (2024-2029)
Table 62. Global Plasma Derived Medicine Sales Market Share by Application (2018-2024)
Table 63. Global Plasma Derived Medicine Sales Market Share by Application (2024-2029)
Table 64. Global Plasma Derived Medicine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Plasma Derived Medicine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Plasma Derived Medicine Revenue Market Share by Application (2018-2024)
Table 67. Global Plasma Derived Medicine Revenue Market Share by Application (2024-2029)
Table 68. Global Plasma Derived Medicine Price (USD/Bottle) by Application (2018-2024)
Table 69. Global Plasma Derived Medicine Price (USD/Bottle) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 73. Takeda Plasma Derived Medicine Product
Table 74. Takeda Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 78. CSL Plasma Derived Medicine Product
Table 79. CSL Recent Developments/Updates
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 83. Grifols Plasma Derived Medicine Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 88. Octapharma Plasma Derived Medicine Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Kedrion Corporation Information
Table 91. Kedrion Description and Business Overview
Table 92. Kedrion Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 93. Kedrion Plasma Derived Medicine Product
Table 94. Kedrion Recent Developments/Updates
Table 95. LFB Group Corporation Information
Table 96. LFB Group Description and Business Overview
Table 97. LFB Group Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 98. LFB Group Plasma Derived Medicine Product
Table 99. LFB Group Recent Developments/Updates
Table 100. Biotest Corporation Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 103. Biotest Plasma Derived Medicine Product
Table 104. Biotest Recent Developments/Updates
Table 105. BPL Corporation Information
Table 106. BPL Description and Business Overview
Table 107. BPL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 108. BPL Plasma Derived Medicine Product
Table 109. BPL Recent Developments/Updates
Table 110. Shanghai RAAS Corporation Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 113. Shanghai RAAS Plasma Derived Medicine Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. China Biologic Products Corporation Information
Table 116. China Biologic Products Description and Business Overview
Table 117. China Biologic Products Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 118. China Biologic Products Plasma Derived Medicine Product
Table 119. China Biologic Products Recent Developments/Updates
Table 120. Hualan Biological Engineering Inc. Corporation Information
Table 121. Hualan Biological Engineering Inc. Description and Business Overview
Table 122. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 123. Hualan Biological Engineering Inc. Plasma Derived Medicine Product
Table 124. Hualan Biological Engineering Inc. Recent Developments/Updates
Table 125. Beijing Tiantan Biological Products Corp Corporation Information
Table 126. Beijing Tiantan Biological Products Corp Description and Business Overview
Table 127. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 128. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product
Table 129. Beijing Tiantan Biological Products Corp Recent Developments/Updates
Table 130. Pacific Shuanglin Corporation Information
Table 131. Pacific Shuanglin Description and Business Overview
Table 132. Pacific Shuanglin Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 133. Pacific Shuanglin Plasma Derived Medicine Product
Table 134. Pacific Shuanglin Recent Developments/Updates
Table 135. Boya Bio-Pharmaceutical Corporation Information
Table 136. Boya Bio-Pharmaceutical Description and Business Overview
Table 137. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 138. Boya Bio-Pharmaceutical Plasma Derived Medicine Product
Table 139. Boya Bio-Pharmaceutical Recent Developments/Updates
Table 140. Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
Table 141. Paisi Feike Biology Pharmacy Co., Ltd. Description and Business Overview
Table 142. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 143. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product
Table 144. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
Table 145. Xinjiang Deyuan Bioengineering Corporation Information
Table 146. Xinjiang Deyuan Bioengineering Description and Business Overview
Table 147. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 148. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product
Table 149. Xinjiang Deyuan Bioengineering Recent Developments/Updates
Table 150. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
Table 151. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Business Overview
Table 152. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 153. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product
Table 154. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 155. Shenzhen Weiguang Corporation Information
Table 156. Shenzhen Weiguang Description and Business Overview
Table 157. Shenzhen Weiguang Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 158. Shenzhen Weiguang Plasma Derived Medicine Product
Table 159. Shenzhen Weiguang Recent Developments/Updates
Table 160. Shanxi Kangbao Corporation Information
Table 161. Shanxi Kangbao Description and Business Overview
Table 162. Shanxi Kangbao Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 163. Shanxi Kangbao Plasma Derived Medicine Product
Table 164. Shanxi Kangbao Recent Developments/Updates
Table 165. Nanyue Biopharming Corporation Ltd Corporation Information
Table 166. Nanyue Biopharming Corporation Ltd Description and Business Overview
Table 167. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 168. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product
Table 169. Nanyue Biopharming Corporation Ltd Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Plasma Derived Medicine Distributors List
Table 173. Plasma Derived Medicine Customers List
Table 174. Plasma Derived Medicine Market Trends
Table 175. Plasma Derived Medicine Market Drivers
Table 176. Plasma Derived Medicine Market Challenges
Table 177. Plasma Derived Medicine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plasma Derived Medicine
Figure 2. Global Plasma Derived Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Plasma Derived Medicine Market Share by Type in 2022 & 2029
Figure 4. Albumin Product Picture
Figure 5. Immune Globulin Product Picture
Figure 6. Coagulation Factor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Plasma Derived Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Plasma Derived Medicine Market Share by Application in 2022 & 2029
Figure 10. Bleeding Wound
Figure 11. Immunodeficiency
Figure 12. HBV
Figure 13. Tetanus
Figure 14. Rabies
Figure 15. Hemophilia
Figure 16. Others
Figure 17. Global Plasma Derived Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Plasma Derived Medicine Market Size (2018-2029) & (US$ Million)
Figure 19. Global Plasma Derived Medicine Sales (2018-2029) & (K Bottles)
Figure 20. Global Plasma Derived Medicine Average Price (USD/Bottle) & (2018-2029)
Figure 21. Plasma Derived Medicine Report Years Considered
Figure 22. Plasma Derived Medicine Sales Share by Manufacturers in 2022
Figure 23. Global Plasma Derived Medicine Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Plasma Derived Medicine Players: Market Share by Revenue in 2022
Figure 25. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Plasma Derived Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Plasma Derived Medicine Sales Market Share by Country (2018-2029)
Figure 28. North America Plasma Derived Medicine Revenue Market Share by Country (2018-2029)
Figure 29. United States Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Mexico Plasma Derived Medicine Revenue Growth Rate (2018-2024) & (US$ Million)
Figure 32. Europe Plasma Derived Medicine Sales Market Share by Country (2018-2029)
Figure 33. Europe Plasma Derived Medicine Revenue Market Share by Country (2018-2029)
Figure 34. Germany Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. France Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. UK Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Italy Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Russia Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Plasma Derived Medicine Sales Market Share by Region (2018-2029)
Figure 40. Asia Pacific Plasma Derived Medicine Revenue Market Share by Region (2018-2029)
Figure 41. China Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Philippines Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Vietnam Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Latin America Plasma Derived Medicine Sales Market Share by Country (2018-2029)
Figure 52. Latin America Plasma Derived Medicine Revenue Market Share by Country (2018-2029)
Figure 53. Brazil Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Plasma Derived Medicine Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Plasma Derived Medicine Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. GCC Countries Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Egypt Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. South Africa Plasma Derived Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Sales Market Share of Plasma Derived Medicine by Type (2018-2029)
Figure 61. Global Revenue Market Share of Plasma Derived Medicine by Type (2018-2029)
Figure 62. Global Plasma Derived Medicine Price (USD/Bottle) by Type (2018-2029)
Figure 63. Global Sales Market Share of Plasma Derived Medicine by Application (2018-2029)
Figure 64. Global Revenue Market Share of Plasma Derived Medicine by Application (2018-2029)
Figure 65. Global Plasma Derived Medicine Price (USD/Bottle) by Application (2018-2029)
Figure 66. Plasma Derived Medicine Value Chain
Figure 67. Plasma Derived Medicine Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed